As the month of April brings testicular cancer into focus, it’s time to increase public understanding of the disease, including […]
Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of testicular cancer educational programs for […]
The incidence of testicular cancer continued to rise in the United States over the past decade, most notably among Hispanic […]
If you’re undergoing chemotherapy, biologic therapy, or radiation to the head or neck area, one of the side effects you […]
Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such […]
Treatment with the chemotherapy agents paclitaxel and Gemzar® (gemcitabine) provides long-term survival and possible cure among some patients with testicular […]
Recurrent Testicular Cancer Potentially Curable with High-dose Therapy and Stem Cell Transplant According to an article recently published in the […]
Surgery Linked with Good Outcomes for Patients with Late Relapse of Metastatic Testicular Cancer Patients who experience a cancer relapse […]
Survivors of Testicular Cancer May Have Increased Risk of Cardiovascular Disease According to a recent article published in the Journal […]
Ifosfamide/Paclitaxel/Cisplatin Highly Effective for Recurrent Testicular Cancer According to results recently published in the Journal of Clinical Oncology, the chemotherapy […]
Stem Cell Transplantation Cures Many Patients with Recurrent Testicular Cancer While the majority of patients with testicular cancer are cured […]
High-dose chemotherapy and stem cell support: a promising therapy for patients with germ cell cancers who have failed chemotherapy.
High-dose chemotherapy and stem cell support: a promising therapy for patients with germ cell cancers who have failed chemotherapy. Treatment […]
Maintenance chemotherapy with daily oral etoposide was effective in patients receiving salvage therapy for germ cell tumors.
Maintenance chemotherapy with daily oral etoposide was effective in patients receiving salvage therapy for germ cell tumors. Treatment of patients […]